Skip to content
★ Sign in to follow
Total declarations
9
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (7 ops.)
€4.0M

Latest filing published 07 Sept 2021 for Certara, Inc., €110k.

Filing timeline

BuySale
Craig R. Rayner

Insider track record

Disclosed buys
0
Disclosed sells
7

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Craig R. Rayner: trading record in brief

Craig R. Rayner (chief executive) discloses dealings in Certara, Inc. to SEC (Form 4). The record holds 9 filings, for trades running from 1 April 2021 to 2 September 2021.

The open-market record consists of 7 sales worth €4.0M, with no purchase. The rest of the record consists of 2 share grants.

On 7 September 2021 came the latest disclosure, an open-market sale for €55k in Certara, Inc. The median gap between a trade and its publication by SEC (Form 4) is 5 days. The legal deadline for a Form 4 is two business days after the transaction. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.

Companies and markets linked to Craig R. Rayner

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations3 total
  • ▼
    PRESIDENT, INTEGRATED DRUG DEVExecutivesCertara, Inc.
    130,689 USD41SEC
    3,900 shares@ US$33.517.7% of flowCommon StockSEC:0001415889-21-004264:0
  • ▼
    PRESIDENT, INTEGRATED DRUG DEVExecutivesCertara, Inc.
    2M USD30SEC
    62,445 shares@ US$25.7092.3% of flowCommon StockSEC:0001415889-21-003013:0
  • ◆
    PRESIDENT, INTEGRATED DRUG DEVExecutivesCertara, Inc.
    0SEC
    38,462 shares0Common StockSEC:0001415889-21-003012:0

3 of 3 declarations